InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Bailey Jeffrey Allen, Chairman & CEO. Insider active across 2 companies, notably Biodelivery Sciences International INC. Aggregated, 7 reports have been published. Activity tracked since 6 August 2021. The latest transaction was disclosed on 21 November 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Bailey Jeffrey Allen is President and Chief Executive Officer. He is associated with Biodelivery Sciences International INC, where he is Chief Executive Officer, and with Aurinia Pharmaceuticals Inc., where he is Director. The record shows 7 filings in total, with sampled filings from 2021-08-10 to 2025-11-24; the most common transaction nature is option exercise, and the cumulative buy and sell amounts in this sample are 0 and 0.